“…Some studies suggest that in GD type 1 patients the accumulation of the immunogenic components in macrophages, such as ceramide and sphingolipids, causes cellular activation and consequently ChT secretion, which may mediate the immune response involved (Ballou et al 1996;van Eijk et al 2005). Increased ChT activity was also recorded in several other diseases, such as Niemann-Pick (Brinkman et al 2005), GM1 gangliosidosis , b-thalassemia (Barone et al 1999), sarcoidosis (Boot et al 2010), malaria (Barone et al 2003), atherosclerosis (Artieda et al 2003;Boot et al 1999), and fungal and bacterial infections (Iyer et al 2009;Labadaridis et al 1998). The role of ChT enzyme is unclear, but a possible role in defense against chitin-containing pathogens and host immune response has been suggested (Choi et al 2001;Di Luca et al 2007;Di Rosa et al 2005;Gordon-Thomson et al 2009;Malaguarnera et al 2005;van Eijk et al 2005).…”